Last week, in an earnings call with analysts, Dominic Caruso, chairman and CEO of Johnson & Johnson, indicated that the diversified conglomerate is interested in the structural heart space.
Here’s what Caruso said in response to an analysts’ question, according to a transcript of the call from Seeking Alpha:
"In the Medical Devices, as you know we have a very strong presence in orthopaedics and in general surgery. We keep looking for additional bolt-on acquisitions there and we have a very strong electrophysiology business in cardiovascular but there are other areas within cardiovascular that seem attractive in structural heart and other areas, but the valuation would be something we’d always consider. So we’d also be very disciplined about doing a transaction where the valuation seem pretty high, which is what they are today."
Here’s what Caruso said in response to an analysts’ question, according to a transcript of the call from Seeking Alpha:
"In the Medical Devices, as you know we have a very strong presence in orthopaedics and in general surgery. We keep looking for additional bolt-on acquisitions there and we have a very strong electrophysiology business in cardiovascular but there are other areas within cardiovascular that seem attractive in structural heart and other areas, but the valuation would be something we’d always consider. So we’d also be very disciplined about doing a transaction where the valuation seem pretty high, which is what they are today."
